2.Correction: Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy.
Yunseon CHOI ; Ki Jung AHN ; Sung Kwang PARK ; Heunglae CHO ; Ji Young LEE
Radiation Oncology Journal 2017;35(4):385-385
The authors noticed that the original version of this paper contains typographical error in Fig. 2.
Body Weight*
;
Humans
;
Radiotherapy*
;
Uterine Cervical Neoplasms*
3.Vaginal evisceration after radical hysterectomy and adjuvant radiation.
Woo Dae KANG ; Seok Mo KIM ; Ho Sun CHOI
Journal of Gynecologic Oncology 2009;20(1):63-64
Vaginal evisceration is a rare complication after a hysterectomy, especially a radical hysterectomy. Up to now, there have only been three cases of transvaginal evisceration after radical hysterectomy reported in the English literature. We report one case of transvaginal evisceration occurring after radical hysterectomy and adjuvant radiotherapy for stage IIA cervical cancer, with a brief review of the literature.
Hysterectomy
;
Radiotherapy, Adjuvant
;
Uterine Cervical Neoplasms
4.The using of megavoltage computed tomography in image-guided brachytherapy for cervical cancer: a case report.
Ekkasit THARAVICHITKUL ; Suwapim JANLA-OR ; Somsak WANWILAIRAT ; Somvilai CHAKRABANDHU ; Pitchayaponne KLUNKLIN ; Wimrak ONCHAN ; Bongkot SUPAWONGWATTANA ; Razvan M GALALAE ; Imjai CHITAPANARUX
Radiation Oncology Journal 2015;33(2):155-159
We present a case of cervical cancer treated by concurrent chemoradiation. In radiation therapy part, the combination of the whole pelvic helical tomotherapy plus image-guided brachytherapy with megavoltage computed tomography of helical tomotherapy was performed. We propose this therapeutic approach could be considered in a curative setting in some problematic situation as our institution.
Brachytherapy*
;
Radiotherapy, Intensity-Modulated
;
Uterine Cervical Neoplasms*
5.The using of megavoltage computed tomography in image-guided brachytherapy for cervical cancer: a case report.
Ekkasit THARAVICHITKUL ; Suwapim JANLA-OR ; Somsak WANWILAIRAT ; Somvilai CHAKRABANDHU ; Pitchayaponne KLUNKLIN ; Wimrak ONCHAN ; Bongkot SUPAWONGWATTANA ; Razvan M GALALAE ; Imjai CHITAPANARUX
Radiation Oncology Journal 2015;33(2):155-159
We present a case of cervical cancer treated by concurrent chemoradiation. In radiation therapy part, the combination of the whole pelvic helical tomotherapy plus image-guided brachytherapy with megavoltage computed tomography of helical tomotherapy was performed. We propose this therapeutic approach could be considered in a curative setting in some problematic situation as our institution.
Brachytherapy*
;
Radiotherapy, Intensity-Modulated
;
Uterine Cervical Neoplasms*
7.Treatment Planning Software for High Dose Rate Remote Afterloading Brachytherapy of Uterine Cervical Cancer.
Seung Jae HUH ; Wee Saing KANG
Journal of the Korean Society for Therapeutic Radiology 1986;4(2):183-186
In brachytherapy of uterine cervical cancer using the high dose rate remote afterloading system, it is of prime importance to determine the position of the radiation sources and to estimate the irradiation time. However, calculation with manual method is so time consuming and laborious, that authors designed a software as an aid to intracavitary radiotherapy planning using the personal computer to obtain the precision of treatment without being too complicated for routine use. Optimal source arrangement in combination with dose rate at each specific points and irradiation time can be easily determined using this software in several minutes.
Brachytherapy*
;
Microcomputers
;
Radiotherapy
;
Uterine Cervical Neoplasms*
8.Activities of erythrocyte antioxidant enzymes and plasma total antioxidant status of the patients with the Ib and IIa stage cervical cancer post radiotherapy treated with Belaf
Journal of Vietnamese Medicine 2005;312(7):37-42
Evaluating activities of erythrocyte antioxidant enzymes and plasma total antioxidant status of 60 patients with the Ib and IIa stage cervical cancer post radiotherapy treated with Belaf and those of 35 healthy controls. The results: Activities of erythrocyte SOD, GPx and GR of the patients significantly decreased compared to those in patients pre radiotherapy. The decrease was likely to recover at the 21st day after radiotherapy. TAS levels of the patients post radiotherapy decreased compared to pre radiotherapy and recovered in 21st day post radiotherapy treated with Belaf
Uterine Cervical Neoplasms
;
Plasma
;
Antioxidants
;
Radiotherapy
9.Activities of erythrocyte antioxidant enzymes and plasma total antioxidant status of the patients with the stage Ib and IIa cervical cancer pre- and post radiotherapy
Journal of Vietnamese Medicine 2004;305(12):18-25
Study on 62 patients with the stage Ib and IIa cervical cancer pre- and post- radiotherapy and 30 healthy controls aged from 30-35 years old. The result showed that activites of antioxidant enzymes (SOD, GPx and GR) of patients with the stage Ib and IIa cervical cancer were significantly decreased compared to those of healthy controls. Activites of these enzyms clearly decreased post-radiotherapy, and more clearly at the 21st day post-radiotherapy. TAS and Hb concentration of cancer patient decreased compared with control group and they trend to recover at the 21st day post-radiotherapy
Enzymes
;
Antioxidants
;
Erythrocytes
;
Uterine Cervical Neoplasms
;
Radiotherapy
10.Therapeutic Results of Surgery and Radiation Therapy in Younger Patients with Stage IB Cervical Cancer.
Gil Cha HUH ; Kwang Mo YANG ; Hyun Suk SUH ; Yong Bong KIM ; Eung Soo LEE ; Sung Kwan PARK
Journal of the Korean Society for Therapeutic Radiology 1995;13(1):49-54
PURPOSE: To evaluate the prognostic importance of age in patients with Stage IB cervical cancer, we examined the relationship between age and survival in patients. METHODS AND MATERIALS: Retrospective analysis was performed on 107 patients were treated with surgery followed by postoperative radiotherapy or radiation alone between October 1983 and August 1993 and 28 patients with Stage IB cervical cancer treated with surgery alone between January 1989 and August 1993 at Inje University Seoul Paik Hospital. Patients ranged in age from 26 to 74 (median 48) and were followed for a median period of 39 months. Patients were divided into two groups; Group A comprising 32 patients with< or=age 40 and Group B comprising 75 patients with>age 40. Both Group A and Group B patients were comparable with respect to all covariables studied. RESULTS: The overall 5-year survival and the disease free 5-year survival for the 107 patients studied were 85.2% and 82.1% respectively. The overall survival for group A and Group B was 92% and 83%, respectively(p>0.05). The disease free 5-year survival for Group A and Group B was 82.3% and 82.6%, respectively(p>0.05). There was no difference in both local and distant failure in Group A and Group B. CONCLUSION: On the basis of the this analysis it is concluded that age alone is a poor indicator of prognosis and should not be used as an indication for adjuvant treatment.
Humans
;
Prognosis
;
Radiotherapy
;
Retrospective Studies
;
Seoul
;
Uterine Cervical Neoplasms*